Corbus Pharmaceut…
USUSDCorbus Pharmaceuticals Holding (US:CRBP) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site Web
- corbuspharma.com
- Relations avec les Investisseurs
- ir.corbuspharma.com/
- Secteur
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siège Social
- Norwood, United States
- PDG
- Yuval Cohen
- Employés
- 36
- Fondée
- 2009
- Actions en Circulation
- 19.34 M au 2026-08-04
- Flottant
- 15.16 M
- Capitalisation Boursière
- 128.23 M USD
- Initiés
- 1.24%
- Investisseurs Institutionnels
- 73.95%
- Secteur d'Activité (SIC)
- Pharmaceutical Preparations
- ISIN
- US21833P3010
- LEI
- 529900MX6XCNZC7MM155
- P/E
- perte
- FCF
- −86.7 M USD
- Dette
- 12.8 M USDtrésorerie nette
- Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
- NAV
Description
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Principaux Actionnaires
| Détenteur | Participation | Actions | Date du Rapport |
|---|---|---|---|
| Cormorant Asset Manageme… | 12.56% | 2.34 M | 2026-06-30 |
| Orbimed Advisors LLC. | 9.3% | 1.74 M | 2026-06-30 |
| Blackrock Inc. | 7.13% | 1.33 M | 2026-06-30 |
| Aberdeen Group plc | 7.08% | 1.32 M | 2026-06-30 |
| abrdn Healthcare Investo… | 4.17% | 778 031 | 2026-06-30 |
| Vanguard Capital Managem… | 4.08% | 760 940 | 2026-06-30 |
| Jones Hill Capital LP | 3.5% | 653 572 | 2026-06-30 |
| Prosight Management, Lp | 3.48% | 650 000 | 2026-06-30 |
| abrdn Life Sciences Inve… | 2.91% | 543 719 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.86% | 533 575 | 2026-06-30 |
| Stonepine Capital Manage… | 2.28% | 425 000 | 2026-06-30 |
| Geode Capital Management… | 2.27% | 423 374 | 2026-06-30 |
| Adar1 Capital Management… | 2.26% | 421 787 | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.13% | 398 086 | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.12% | 208 310 | 2026-06-30 |
| Fidelity Salem Street Tr… | 0.96% | 179 556 | 2026-07-31 |
| COHEN YUVAL (Chief Execu… | ≈0.84% | 157 316 | 2026-08-07 |
| iShares Trust-iShares Ru… | 0.83% | 154 662 | 2026-07-31 |
| SMETHURST DOMINIC (Offic… | ≈0.48% | 89 790 | 2026-03-02 |
| Fidelity Covington Trust… | 0.47% | 87 387 | 2026-08-31 |
| MORAN SEAN F (Chief Fina… | ≈0.45% | 84 694 | 2026-08-07 |
| SAXENA NISHANT C (Office… | ≈0.42% | 77 900 | 2026-08-11 |
| NICACIO LEONARDO VIANA M… | ≈0.31% | 58 333 | 2026-08-14 |
| Dimensional ETF Trust-Di… | 0.31% | 58 383 | 2026-07-31 |
| iShares Trust-iShares Mi… | 0.29% | 54 624 | 2026-07-31 |
| HODGSON IAN (Chief Opera… | ≈0.27% | 51 080 | 2026-02-17 |
| KUNG WINSTON (Director) | ≈0.07% | 12 140 | 2026-06-10 |
| JACQUES RACHELLE SUZANNE… | ≈0.06% | 11 383 | 2026-05-19 |
| HOLMER ALAN F (Director) | ≈0.06% | 10 629 | 2025-05-30 |
| CORMORANT ASSET MANAGEME… | — | — | 2025-12-11 |
